摘要
目的探讨重组人干扰素α2a联合拉米夫定治疗慢性乙型肝炎的疗效。方法慢性乙型肝炎患者160例,随机分成观察组和对照组。对照组给予干扰素治疗,观察组给予干扰素联合拉米夫定治疗。结果观察组总有效率77.50%高于对照组62.50%,差异有统计学意义(P<0.05)。结论重组人干扰素α2a联合拉米夫定治疗慢性乙型肝炎疗效可靠。
Objective To discuss of Interferon combined with lamivudine in treating of chronic hepatitis B.Methods 160 patients with chronic hepatitis were randomly divided into the observation group and the control group.Control group was given interferon treatment,observation group received interferon and lamivudine therapy.Results The total efficiency of the observation group was 77.50% higher than 62.50% that of control group,significant difference（P0.05）.Conclusion Interferon combined with lamivudine in treating chronic hepatitis B with reliable curative effect.
出处
《中国实用医药》
2012年第36期29-30,共2页
China Practical Medicine
